12.5 C
London
Thursday, September 21, 2023

Emerging Growth Conference 62 September 6 & 7. Register now

ASX Commentary

Discussion about stocks trading on the Australian Stock Exchange ASX from professionals in the Australian stock and investing profession

$1.87 million raised in oversubscribed Shortfall facility

MELBOURNE Australia, 13 July 2023: AdAlta Limited (ASX:1AD), the clinical stage drug discovery company developing novel therapeutic products from its i-body platform is pleased...

New AD-214 Data Links Phase I Results With Efficacy; De-Risks Clinical Dosing Schedule

Key points: • New data favourably links AD-214 preclinical animal studies and Phase I human clinical trial results to provide important dose frequency insights • AD-214 is designed to...

AdAlta (ASX: 1AD) IMPORTANT PHASE I EXTENSION CLINICAL STUDY OF AD-214 APPROVED

29 June 2023 ASX Announcement IMPORTANT PHASE I EXTENSION CLINICAL STUDY OF AD-214 APPROVED Key highlights: Human Research Ethics Committee (HREC) has approved Phase I extension...

Rat’s Rant – The Black Friday Edition

What's Hot - LIN, ASN, ADN, BAR, GAS, ICU, PM1, TSO, VTI, DAV, CHN, TNY & GGGWhat's Not - My FingersWhat's Doing - Hump...

Rat’s Rant – The Nintendo Edition

Rat's Rant - The Nintendo Edition

Rat’s Rant – The George Bush Terror Edition

Rat's Rant - The George Bush Terror Edition

Rat’s Rant – The Wall Street Bomb Edition

What's Hot - EER, GGE, ICI, CLA, FPL, SHE, TEG, WWI, BNL & CYPWhat's Not - FFRWhat's Doing - 5GN (Q&A With Joe Demase) To subscribe...

Rat’s Rant – The Golden Girls Edition

Rat's Rant - The Golden Girls Edition

Rat’s Rant – The Russian Bomb Edition

What's Hot - TSC, FFR, CCA, DEV, CAV, RIM, MYQ, 88E, BNL & 3DA What's Not - NEA & BRNWhat's Doing - Thanks to the reader...

Rat’s Rant – The French Execution Edition

What's Hot - JXT, LCL, QFY, DRO, SHO, 3DA, TMT, PUR, AQD & AGH What's Not - MYRWhat's Doing - AGH (Medical Pot play that I...

Latest News